{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:58:58Z","timestamp":1768352338146,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Liaoning Provincial Natural Science Foundation Project","award":["NO. 20180550523"],"award-info":[{"award-number":["NO. 20180550523"]}]},{"name":"Liaoning Province Central Government's special project to guide local scientific and technological development","award":["NO.2019JH6\/10400009"],"award-info":[{"award-number":["NO.2019JH6\/10400009"]}]},{"name":"Major Special Project of Construction Program of China Medical University in 2018","award":["NO.112\/3110118034"],"award-info":[{"award-number":["NO.112\/3110118034"]}]},{"name":"Guangdong Province Major key projects of industrial technology","award":["NO.201902010003"],"award-info":[{"award-number":["NO.201902010003"]}]},{"name":"The 345 Talent Project of Shengjing Hospital of China Medical University","award":["NO.50A"],"award-info":[{"award-number":["NO.50A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Idiopathic membranous nephropathy (IMN) is a cause of nephrotic syndrome that is increasing in incidence but has unclear pathogenesis. Urinary peptidomics is a promising technology for elucidating molecular mechanisms underlying diseases. Dysregulation of the proteolytic system is implicated in various diseases. Here, we aimed to conduct urinary peptidomics to identify IMN-related proteases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Peptide fingerprints indicated differences in naturally produced urinary peptide components among 20 healthy individuals, 22 patients with IMN, and 15 patients with other kidney diseases. In total, 1,080 peptide-matched proteins were identified, 279 proteins differentially expressed in the urine of IMN patients were screened, and 32 proteases were predicted; 55 of the matched proteins were also differentially expressed in the kidney tissues of IMN patients, and these were mainly involved in the regulation of proteasome-, lysosome-, and actin cytoskeleton-related signaling pathways. The 32 predicted proteases showed abnormal expression in the glomeruli of IMN patients based on Gene Expression Omnibus databases. Western blot revealed abnormal expression of calpain, matrix metalloproteinase 14, and cathepsin S in kidney tissues of patients with IMN.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This work shown the calpain\/matrix metalloproteinase\/cathepsin axis might be dysregulated in IMN. Our study is the first to systematically explore the role of proteases in IMN by urinary peptidomics, which are expected to facilitate discovery of better biomarkers for IMN.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12864-021-08155-3","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T21:03:13Z","timestamp":1637787793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Urinary peptidomics reveals proteases involved in idiopathic membranous nephropathy"],"prefix":"10.1186","volume":"22","author":[{"given":"Baoxu","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yabin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibo","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"8155_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.11761116","volume":"12","author":"WG Couser","year":"2017","unstructured":"Couser W G. Primary Membranous Nephropathy. Clin J Am Soc Nephrol. 2017;12:983\u201397.","journal-title":"Clin J Am Soc Nephrol"},{"key":"8155_CR2","doi-asserted-by":"crossref","unstructured":"Rovin BH, Caster DJ, Cattran DC, Gibson KL, Hogan JJ, Moeller MJ, Roccatello D, Cheung M, Wheeler DC, Winkelmayer WC, Floege J; Conference Participants. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;95:281-95.","DOI":"10.1016\/j.kint.2018.11.008"},{"key":"8155_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","volume":"6","author":"JB Kopp","year":"2020","unstructured":"Kopp JB, Anders HJ, Susztak K, Podest\u00e0 MA, Remuzzi G, Hildebrandt F, Romagnani P. Podocytopathies. Nat Rev Dis Primers. 2020;6:68.","journal-title":"Nat Rev Dis Primers"},{"key":"8155_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/postgradmedj-2018-135729","volume":"95","author":"KC Keri","year":"2019","unstructured":"Keri KC, Blumenthal S, Kulkarni V, Beck L, Chongkrairatanakul T. Primary membranous nephropathy: comprehensive review and historical perspective. Postgrad Med J. 2019;95:23\u20131.","journal-title":"Postgrad Med J"},{"key":"8155_CR5","first-page":"49","volume":"241","author":"I Thokhonelidze","year":"2015","unstructured":"Thokhonelidze I, Maglakelidze N, Sarishvili N, Kasradze T, Dalakishvili K. Association of anti-phospholipasea2-receptor antibodies with clinical course of idiopathic membranous nephropathy. Georgian Med News. 2015;241:49\u201353.","journal-title":"Georgian Med News"},{"key":"8155_CR6","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1172\/JCI32022","volume":"117","author":"S Sever","year":"2007","unstructured":"Sever S, Altintas MM, Nankoe SR, M\u00f6ller CC, Ko D, Wei C, Henderson J, del Re EC, Hsing L, Erickson A, Cohen CD, Kretzler M, Kerjaschki D, Rudensky A, Nikolic B, Reiser J. Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest. 2007;117:2095\u2013104.","journal-title":"J Clin Invest"},{"key":"8155_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrneph.2015.177","volume":"12","author":"T Madhusudhan","year":"2016","unstructured":"Madhusudhan T, Kerlin BA, Isermann B. The emerging role of coagulation proteases in kidney disease. Nat Rev Nephrol. 2016;12:94\u2013109.","journal-title":"Nat Rev Nephrol"},{"key":"8155_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrd4390","volume":"13","author":"RE Vandenbroucke","year":"2014","unstructured":"Vandenbroucke RE, Libert C. Is there new hope for therapeutic matrix metalloproteinase inhibition?. Nat Rev Drug Discov. 2014;13:904\u2013927.","journal-title":"Nat Rev Drug Discov"},{"key":"8155_CR9","doi-asserted-by":"publisher","first-page":"17454","DOI":"10.1074\/jbc.M114.568998","volume":"289","author":"MM Altintas","year":"2014","unstructured":"Altintas MM, Moriwaki K, Wei C, M\u00f6ller CC, Flesche J, Li J, Yaddanapudi S, Faridi MH, G\u00f6del M, Huber TB, Preston RA, Jiang JX, Kerjaschki D, Sever S, Reiser J. Reduction of proteinuria through podocyte alkalinization. J Biol Chem. 2014;289:17454\u201367.","journal-title":"J Biol Chem"},{"key":"8155_CR10","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1373\/clinchem.2013.211714","volume":"60","author":"JM Bau\u00e7a","year":"2014","unstructured":"Bau\u00e7a JM, Mart\u00ednez-Morillo E, Diamandis EP. Peptidomics of urine and other biofluids for cancer diagnostics. Clin Chem. 2014;60:1052\u201361.","journal-title":"Clin Chem"},{"key":"8155_CR11","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1681\/ASN.2016091018","volume":"28","author":"JAD Van","year":"2017","unstructured":"Van JAD, Scholey JW, Konvalinka A. Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics. J Am Soc Nephrol. 2017;28:1050\u201361.","journal-title":"J Am Soc Nephrol"},{"key":"8155_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4137\/BMI.S26229","volume":"11","author":"L Santucci","year":"2016","unstructured":"Santucci L, Bruschi M, Candiano G, Lugani F, Petretto A, Bonanni A, Ghiggeri GM. Urine Proteome Biomarkers in Kidney Diseases. I. Limits, Perspectives, and First Focus on Normal Urine. Biomark Insights. 2016;11:41\u20138.","journal-title":"Biomark Insights"},{"key":"8155_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrg.2018.4","volume":"19","author":"KJ Karczewski","year":"2018","unstructured":"Karczewski KJ, Snyder MP. Integrative omics for health and disease. Nat Rev Genet. 2018;19:299\u2013310.","journal-title":"Nat Rev Genet"},{"key":"8155_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1471-2369-14-82","volume":"14","author":"F Graterol","year":"2013","unstructured":"Graterol F, Navarro-Mu\u00f1oz M, Ibernon M, L\u00f3pez D, Troya MI, P\u00e9rez V, Bonet J, Romero R. Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling. BMC Nephrol. 2013;14:82.","journal-title":"BMC Nephrol"},{"key":"8155_CR15","doi-asserted-by":"publisher","first-page":"15160","DOI":"10.1038\/s41598-017-15359-9","volume":"7","author":"M Krochmal","year":"2017","unstructured":"Krochmal M, Kontostathi G, Magalh\u00e3es P, Makridakis M, Klein J, Husi H, Leierer J, Mayer G, Bascands JL, Denis C, Zoidakis J, Z\u00fcrbig P, Delles C, Schanstra JP, Mischak H, Vlahou A. Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy. Sci Rep. 2017;7:15160.","journal-title":"Sci Rep"},{"key":"8155_CR16","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1681\/ASN.2014050423","volume":"26","author":"JP Schanstra","year":"2015","unstructured":"Schanstra JP, Z\u00fcrbig P, Alkhalaf A, Argiles A, Bakker SJ, Beige J, Bilo HJ, Chatzikyrkou C, Dakna M, Dawson J, Delles C, Haller H, Haubitz M, Husi H, Jankowski J, Jerums G, Kleefstra N, Kuznetsova T, Maahs DM, Menne J, Mullen W, Ortiz A, Persson F, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Siwy J, Snell-Bergeon J, Spasovski G, Staessen JA, Vlahou A, Mischak H, Vanholder R. Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides. J Am Soc Nephrol. 2015;26:1999\u20132010.","journal-title":"J Am Soc Nephrol"},{"key":"8155_CR17","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/s41416-020-01063-5","volume":"123","author":"T Shimura","year":"2020","unstructured":"Shimura T, Dayde D, Wang H, Okuda Y, Iwasaki H, Ebi M, Kitagawa M, Yamada T, Yamada T, Hanash SM, Taguchi A, Kataoka H. Novel urinary protein biomarker panel for early diagnosis of gastric cancer. Br J Cancer. 2020;123:1656\u20131664.","journal-title":"Br J Cancer"},{"key":"8155_CR18","doi-asserted-by":"publisher","first-page":"e13257","DOI":"10.15252\/emmm.202013257","volume":"13","author":"S Virreira Winter","year":"2021","unstructured":"Virreira Winter S, Karayel O, Strauss MT, Padmanabhan S, Surface M, Merchant K, Alcalay RN, Mann M. Urinary proteome profiling for stratifying patients with familial Parkinson\u2019s disease. EMBO Mol Med. 2021;13:e13257.","journal-title":"EMBO Mol Med"},{"key":"8155_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fcell.2017.00114","volume":"5","author":"P Cocchiaro","year":"2017","unstructured":"Cocchiaro P, De Pasquale V, Della Morte R, Tafuri S, Avallone L, Pizard A, Moles A, Pavone LM. The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease. Front Cell Dev Biol. 2017;5:114.","journal-title":"Front Cell Dev Biol"},{"key":"8155_CR20","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1681\/ASN.2018070729","volume":"30","author":"LK Farmer","year":"2019","unstructured":"Farmer LK, Rollason R, Whitcomb DJ, Ni L, Goodliff A, Lay AC, Birnbaumer L, Heesom KJ, Xu SZ, Saleem MA, Welsh GI. TRPC6 Binds to and Activates Calpain, Independent of Its Channel Activity, and Regulates Podocyte Cytoskeleton, Cell Adhesion, and Motility. J Am Soc Nephrol. 2019;30:1910\u201324.","journal-title":"J Am Soc Nephrol"},{"key":"8155_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000499876","volume":"44","author":"O Zakiyanov","year":"2019","unstructured":"Zakiyanov O, Kalousov\u00e1 M, Zima T, Tesa\u0159 V. Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal. Kidney Blood Press Res. 2019;44:298\u2013330.","journal-title":"Kidney Blood Press Res"},{"key":"8155_CR22","first-page":"2079","volume":"32","author":"J Siwy","year":"2017","unstructured":"Siwy J, Z\u00fcrbig P, Argiles A, Beige J, Haubitz M, Jankowski J, Julian BA, Linde PG, Marx D, Mischak H, Mullen W, Novak J, Ortiz A, Persson F, Pontillo C, Rossing P, Rupprecht H, Schanstra JP, Vlahou A, Vanholder R. Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis. Nephrol Dial Transplant. 2017;32:2079\u20132089.","journal-title":"Nephrol Dial Transplant"},{"key":"8155_CR23","doi-asserted-by":"publisher","first-page":"e0122950","DOI":"10.1371\/journal.pone.0122950","volume":"10","author":"M Zhang","year":"2015","unstructured":"Zhang M, Fu G, Lei T. Two urinary peptides associated closely with type 2 diabetes mellitus. PLoS One. 2015;10:e0122950.","journal-title":"PLoS One"},{"key":"8155_CR24","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1021\/acs.jproteome.5b00981","volume":"15","author":"C Lazar","year":"2016","unstructured":"Lazar C, Gatto L, Ferro M, Bruley C, Burger T. Accounting for the Multiple Natures of Missing Values in Label-Free Quantitative Proteomics Data Sets to Compare Imputation Strategies. J Proteome Res. 2016;15:1116\u201325.","journal-title":"J Proteome Res"},{"key":"8155_CR25","first-page":"57","volume":"25","author":"J Jing","year":"2018","unstructured":"Jing J, Gao Y. Urine biomarkers in the early stages of diseases: current status and perspective. Discov Med. 2018;25:57\u201365.","journal-title":"Discov Med"},{"key":"8155_CR26","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1021\/pr060122b","volume":"5","author":"HH Ngai","year":"2006","unstructured":"Ngai HH, Sit WH, Jiang PP, Xu RJ, Wan JM, Thongboonkerd V. Serial changes in urinary proteome profile of membranous nephropathy: implications for pathophysiology and biomarker discovery. J Proteome Res. 2006;5:3038\u201347.","journal-title":"J Proteome Res"},{"key":"8155_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12014-018-9183-3","volume":"15","author":"L Pang","year":"2018","unstructured":"Pang L, Li Q, Li Y, Liu Y, Duan N, Li H. Urine proteomics of primary membranous nephropathy using nanoscale liquid chromatography tandem mass spectrometry analysis. Clin Proteomics. 2018;15:5.","journal-title":"Clin Proteomics"},{"key":"8155_CR28","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/s41598-020-58067-7","volume":"10","author":"LA Brondani","year":"2020","unstructured":"Brondani LA, Soares AA, Recamonde-Mendoza M, Dall\u2019Agnol A, Camargo JL, Monteiro KM, Silveiro SP. Urinary peptidomics and bioinformatics for the detection of diabetic kidney disease. Sci Rep. 2020;10:1242.","journal-title":"Sci Rep"},{"key":"8155_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41576-020-0258-4","volume":"21","author":"C Buccitelli","year":"2020","unstructured":"Buccitelli C, Selbach M. mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet. 2020;21:630\u2013644.","journal-title":"Nat Rev Genet"},{"key":"8155_CR30","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1073\/pnas.1404059112","volume":"112","author":"K Liu","year":"2015","unstructured":"Liu K, Lyu L, Chin D, Gao J, Sun X, Shang F, Caceres A, Chang ML, Rowan S, Peng J, Mathias R, Kasahara H, Jiang S, Taylor A. Altered ubiquitin causes perturbed calcium homeostasis, hyperactivation of calpain, dysregulated differentiation, and cataract. Proc Natl Acad Sci USA. 2015;112:1071\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8155_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature07451","volume":"456","author":"RA Hanna","year":"2008","unstructured":"Hanna RA, Campbell RL, Davies PL. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature. 2008;456:409\u2013412.","journal-title":"Nature"},{"key":"8155_CR32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.apsb.2015.08.001","volume":"5","author":"M Siklos","year":"2015","unstructured":"Siklos M, BenAissa M, Thatcher GR. Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors. Acta Pharm Sin B. 2015;5:506\u2013519.","journal-title":"Acta Pharm Sin B"},{"key":"8155_CR33","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.bbadis.2019.04.001","volume":"1865","author":"SE Dryer","year":"2019","unstructured":"Dryer SE, Roshanravan H, Kim EY. TRPC channels: Regulation, dysregulation and contributions to chronic kidney disease. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1041\u20131066.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"8155_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbamcr.2008.11.001","volume":"1793","author":"GM Salido","year":"2009","unstructured":"Salido GM, Sage SO, Rosado JA. TRPC channels and store-operated Ca(2+) entry. Biochim Biophys Acta. 2009;1793:223\u201330.","journal-title":"Biochim Biophys Acta"},{"key":"8155_CR35","doi-asserted-by":"publisher","first-page":"e102065","DOI":"10.1371\/journal.pone.0102065","volume":"9","author":"JM Hofstra","year":"2014","unstructured":"Hofstra JM, Coenen MJ, Schijvenaars MM, Berden JH, van der Vlag J, Hoefsloot LH, Knoers NV, Wetzels JF, Nijenhuis T. TRPC6 single nucleotide polymorphisms and progression of idiopathic membranous nephropathy. PLoS One. 2014;9:e102065.","journal-title":"PLoS One"},{"key":"8155_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.survophthal.2007.12.006","volume":"53","author":"M Azuma","year":"2008","unstructured":"Azuma M, Shearer TR. The role of calcium-activated protease calpain in experimental retinal pathology. Surv Ophthalmol. 2008;53:150\u2013163.","journal-title":"Surv Ophthalmol"},{"key":"8155_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/1097-4644(20010101)80:1<53::AID-JCB60>3.0.CO;2-E","volume":"80","author":"G Gao","year":"2000","unstructured":"Gao G, Dou QP. N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. J Cell Biochem. 2000;80:53\u201372.","journal-title":"J Cell Biochem"},{"key":"8155_CR38","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1093\/ndt\/gfs373","volume":"27","author":"A Linkermann","year":"2012","unstructured":"Linkermann A, De Zen F, Weinberg J, Kunzendorf U, Krautwald S. Programmed necrosis in acute kidney injury. Nephrol Dial Transplant. 2012;27:3412\u20133419.","journal-title":"Nephrol Dial Transplant"},{"key":"8155_CR39","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1046\/j.1460-9568.1998.00184.x","volume":"10","author":"T Yamashima","year":"1998","unstructured":"Yamashima T, Kohda Y, Tsuchiya K, Ueno T, Yamashita J, Yoshioka T, Kominami E. Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on \u2018calpain-cathepsin hypothesis\u2019. Eur J Neurosci. 1998;10:1723\u201333.","journal-title":"Eur J Neurosci"},{"key":"8155_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3565","volume":"14","author":"C Settembre","year":"2013","unstructured":"Settembre C, Fraldi A, Medina DL, Ballabio A. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol. 2013;14:283\u2013296.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8155_CR41","doi-asserted-by":"publisher","first-page":"e0233639","DOI":"10.1371\/journal.pone.0233639","volume":"15","author":"JAD Van","year":"2020","unstructured":"Van JAD, Clotet-Freixas S, Hauschild AC, Batruch I, Jurisica I, Elia Y, Mahmud FH, Sochett E, Diamandis EP, Scholey JW, Konvalinka A. Urinary proteomics links keratan sulfate degradation and lysosomal enzymes to early type 1 diabetes. PLoS One. 2020;15:e0233639.","journal-title":"PLoS One"},{"key":"8155_CR42","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/jama.2011.1246","volume":"306","author":"E Jobs","year":"2011","unstructured":"Jobs E, Ingelsson E, Ris\u00e9rus U, Nerpin E, Jobs M, Sundstr\u00f6m J, Basu S, Larsson A, Lind L, \u00c4rnl\u00f6v J. Association between serum cathepsin S and mortality in older adults. JAMA. 2011;306:1113\u201321.","journal-title":"JAMA"},{"key":"8155_CR43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/toxsci\/kfg073","volume":"73","author":"A Luhe","year":"2003","unstructured":"Luhe A, Hildebrand H, Bach U, Dingermann T, Ahr HJ. A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays. Toxicol Sci. 2003;73:315\u201328.","journal-title":"Toxicol Sci"},{"key":"8155_CR44","doi-asserted-by":"publisher","first-page":"43538","DOI":"10.1038\/srep43538","volume":"7","author":"D Steubl","year":"2017","unstructured":"Steubl D, Kumar SV, Tato M, Mulay SR, Larsson A, Lind L, Ris\u00e9rus U, Renders L, Heemann U, Carlsson AC, \u00c4rnl\u00f6v J, Anders HJ. Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans. Sci Rep. 2017;7:43538.","journal-title":"Sci Rep"},{"key":"8155_CR45","doi-asserted-by":"publisher","first-page":"F1351-F1361","DOI":"10.1152\/ajprenal.00037.2012","volume":"302","author":"RJ Tan","year":"2012","unstructured":"Tan RJ, Liu Y. Matrix metalloproteinases in kidney homeostasis and diseases. Am J Physiol Renal Physiol. 2012;302:F1351-F1361.","journal-title":"Am J Physiol Renal Physiol"},{"key":"8155_CR46","first-page":"2445","volume":"45","author":"X Hu","year":"2010","unstructured":"Hu X, Beeton C. Detection of functional matrix metalloproteinases by zymography. J Vis Exp. 2010;45:2445.","journal-title":"J Vis Exp"},{"key":"8155_CR47","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/ijms18040776","volume":"18","author":"Z Cheng","year":"2017","unstructured":"Cheng Z, Limbu MH, Wang Z, Liu J, Liu L, Zhang X, Chen P, Liu B. MMP-2 and 9 in Chronic Kidney Disease. Int J Mol Sci. 2017;18:776.","journal-title":"Int J Mol Sci"},{"key":"8155_CR48","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/biom10010154","volume":"10","author":"M Provenzano","year":"2020","unstructured":"Provenzano M, Andreucci M, Garofalo C, Faga T, Michael A, Ielapi N, Grande R, Sapienza P, Franciscis S, Mastroroberto P, Serra R. The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel? Biomolecules. 2020;10:154.","journal-title":"Biomolecules"},{"key":"8155_CR49","doi-asserted-by":"crossref","unstructured":"Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1-13.","DOI":"10.1093\/nar\/gkn923"},{"key":"8155_CR50","doi-asserted-by":"crossref","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","DOI":"10.1093\/nar\/28.1.27"},{"issue":"11","key":"8155_CR51","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28(11):1947\u20131951.","journal-title":"Protein Sci"},{"issue":"D1","key":"8155_CR52","doi-asserted-by":"publisher","first-page":"D545-D551","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545-D551.","journal-title":"Nucleic Acids Res"},{"key":"8155_CR53","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/bioinformatics\/btv557","volume":"32","author":"M Franz","year":"2016","unstructured":"Franz M, Lopes CT, Huck G, Dong Y, Sumer O, Bader GD. Cytoscape.js: a graph theory library for visualisation and analysis. Bioinformatics. 2016;32:309\u201311.","journal-title":"Bioinformatics."},{"key":"8155_CR54","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman WH, Pag\u00e8s F, Trajanoski Z, Galon J. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25:1091\u20133.","journal-title":"Bioinformatics"},{"key":"8155_CR55","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1089\/cmb.2018.0050","volume":"25","author":"S Wang","year":"2018","unstructured":"Wang S, Zheng W, Hu L, Gong M, Yang H. MixProTool: A Powerful and Comprehensive Web Tool for Analyzing and Visualizing Multigroup Proteomics Data. J Comput Biol. 2018;25:1123\u201327.","journal-title":"J Comput Biol"},{"key":"8155_CR56","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/pmic.201200493","volume":"13","author":"J Klein","year":"2013","unstructured":"Klein J, Eales J, Z\u00fcrbig P, Vlahou A, Mischak H, Stevens R. Proteasix: a tool for automated and large-scale prediction of proteases involved in naturally occurring peptide generation. Proteomics. 2013;13:1077\u201382.","journal-title":"Proteomics"},{"key":"8155_CR57","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1038\/s41467-019-13382-0","volume":"10","author":"A Subramanian","year":"2019","unstructured":"Subramanian A, Sidhom EH, Emani M, Vernon K, Sahakian N, Zhou Y, Kost-Alimova M, Slyper M, Waldman J, Dionne D, Nguyen LT, Weins A, Marshall JL, Rosenblatt-Rosen O, Regev A, Greka A. Single cell census of human kidney organoids shows reproducibility and diminished off-target cells after transplantation. Nat Commun. 2019;10:5462.","journal-title":"Nat Commun"},{"key":"8155_CR58","doi-asserted-by":"publisher","first-page":"D1211-D1217","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma J, Chen T, Wu S, Yang C, Bai M, Shu K, Li K, Zhang G, Jin Z, He F, Hermjakob H, Zhu Y. iProX: an integrated proteome resource. Nucleic Acids Res. 2019;47:D1211-D1217.","journal-title":"Nucleic Acids Res"},{"key":"8155_CR59","first-page":"1226","volume":"77","author":"PC Grayson","year":"2018","unstructured":"Grayson PC, Eddy S, Taroni JN, Lightfoot YL, Mariani L, Parikh H, Lindenmeyer MT, Ju W, Greene CS, Godfrey B, Cohen CD, Krischer J, Kretzler M, Merkel PA; Vasculitis Clinical Research Consortium, the European Renal cDNA Bank cohort, and the Nephrotic Syndrome Study Network. Metabolic pathways and immunometabolism in rare kidney diseases. Ann Rheum Dis. 2018;77:1226\u201333.","journal-title":"Ann Rheum Dis"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-021-08155-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12864-021-08155-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-021-08155-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T06:05:36Z","timestamp":1675922736000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-021-08155-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["8155"],"URL":"https:\/\/doi.org\/10.1186\/s12864-021-08155-3","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]},"assertion":[{"value":"5 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Shengjing Hospital of China Medical University (No.2019PS194K); the requirement for informed consent of patients was waived by this committee. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"852"}}